摘要
强迫症是一种以强迫观念、强迫冲动或强迫行为等强迫症状为主要临床表现的慢性、易复发、易致残性精神障碍,在一般人群中的发病率为1.1%~3.3%。抗强迫症治疗有效率为40%~67%,相当高比例的强迫症患者抗强迫治疗无效[1]。本研究以探讨小剂量齐拉西酮作为增效治疗强迫症的疗效和安全性。
出处
《实用医技杂志》
2011年第12期1319-1320,共2页
Journal of Practical Medical Techniques
参考文献7
-
1刘家洪,许毅.难治性强迫症治疗中增效剂应用进展[J].国际精神病学杂志,2011,38(3):175-179. 被引量：6
-
2Kordon A,Wahl K,Koch N,et al.Quuetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive -compulsive disorder:a double-blind,randomized,placebo-controlled study.J Clin Psychopharmacol,2008,28(5):550-554.
-
3McDougle CJ,Goodman WK,Price LH.Dopamine antagonists in ticielated and psychotic spectrum obsessive compulsive disorder.J Clin Psychiatry,1994,55(Suppl):24-31.
-
4Stein DJ.Neurobiology of the obsessive compulsive spectrum disorders.Biol Psychiatry,2000,47(4):296-304.
-
5Bloch MH,Landeros-Wisenberger A,Kelmendi B,et al.A systematic review:antipsychotic augmentation with treatment refractory obsessive -compulsive disorder.Mol Psychiatry,2006,11(7):622-632.
-
6王素芬,黄婷,范文澜,刘国清.齐拉西酮作为增效剂治疗难治性强迫症疗效观察[J].医学信息,2010,23(13):2154-2155. 被引量：2
-
7Khullar A,Chue P,Tibbo P.Quetiapine and obsessive-compulsive symptoms:care report and review of atypical antipsychoticinduced OCS.J Psychiatry Neurosci,2001,26(1):55-59.
二级参考文献18
-
1杨海晨,熊雪莲,余常红.奎硫平作为增效剂治疗难治性强迫症疗效观察[J].临床心身疾病杂志,2005,11(1):15-16. 被引量：3
-
2喻东山.强迫症治疗的新进展[J].中华精神科杂志,2005,38(1):50-52. 被引量：65
-
3陶林.对难治性强迫障碍的治疗对策[J].国外医学（精神病学分册）,1996,23(1):30-35. 被引量：13
-
4Hollander E, Bienstock C, Koran LM, et al. Refractory obsessive - compulsive disorder: state - of - the - art treatment. J Clin Psychiatry, 2002 ; 63 (suppl6) :20 - 29.
-
5Denys D, van Megen H, Westenberg H. Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment - refractory obsessive - compulsive disorder: an openlabel study. J Clin Psychiatry, 2002 ; 63 ( 8 ) :700.
-
6Skapinakis P, Papatheodorou T, Mavreas V. Antipsychotic augmentation of serotonergic antidepressants in treatment - resistant obsessive - compulsive disorder: a metaanalysis of the randomized controlled trials. Eur Neuropsychopharmacol, 2007;17(2) :79 -93.
-
7Matsunaga H, Nagata T, Hayasbida K, et al. A longterm trim of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI - refractory obsessive - compulsive disorder. Clin Neuropharmacol, 2009 ; 32 ( 3 ) : 174 - 176.
-
8Husted DS, Shapira NA. A review of the treatment for refractory Obsessive- compulsive disorder: from medicine to deep brain stimulation. CNS Spectr. 2004 ;9:833 - 847.
-
9Maina G, Albet U, Ziero S, et al. Antipsychotic augmentation for treatment resistant obsessive - compulsive disorder: what if antipsychotic is discontinued? Int Clin Psyehopharmacol, 2003;18 ( 1 ) :2.
-
10Iwata Y, Kotani Y, Hoshino R, et al. Carbamazepine augmentation of clomipramine in the treatment of refractory obsessive- compulsive disorder. J Clin Psychiatry,2000; 61 (7) :528.
共引文献5
-
1谢艳红.齐拉西酮对强迫症患者增效治疗的临床观察[J].按摩与康复医学,2012,3(20):71-71.
-
2倪俊芝,赵双桅.舍曲林联合阿立哌唑治疗强迫症的临床观察[J].现代药物与临床,2012,27(6):592-594. 被引量：4
-
3李海杰.齐拉西酮对强迫症增效治疗的临床研究[J].中国医药指南,2015,13(20):164-164. 被引量：3
-
4潘爱祖,潘隽峰.舍曲林合并利培酮治疗难治性强迫症的临床疗效评价[J].海峡药学,2016,28(11):141-142. 被引量：4
-
5郭玲玲,贺俊严.利培酮及氟伏沙明联合用药对难治性强迫症的治疗效果分析[J].中国医药指南,2017,15(23):159-160. 被引量：2
同被引文献8
-
1丁书申,闻荣海.齐拉西酮对精神障碍伴强迫症状的疗效观察[J].中外健康文摘,2011,8(19):30-31.
-
2Selvi Y, Atli A, Aydin A, et al. The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study[J]. Hum Psychopharmaeol,2011,26(1) :51-57.
-
3McD onald DM,Teicher BA,Stetler Stevenson W,et al.Report from the society for biological therapy and vascular biology faculty of the NCI workshop on angiogenesis monitoring[J].J Immunotherapy,2004,27(2):161.
-
4季建林.强迫症的治疗现状[J].世界临床药物,2010,31(4):199-201. 被引量：3
-
5王素芬,黄婷,范文澜,刘国清.齐拉西酮作为增效剂治疗难治性强迫症疗效观察[J].医学信息,2010,23(13):2154-2155. 被引量：2
-
6刘家洪,许毅.难治性强迫症治疗中增效剂应用进展[J].国际精神病学杂志,2011,38(3):175-179. 被引量：6
-
7何俊,王玉文,王泽民.齐拉西酮研究进展[J].医药导报,2011,30(12):1613-1616. 被引量：12
-
8李新峰.舍曲林联合齐拉西酮治疗强迫症的临床效果[J].中国当代医药,2014,21(6):69-70. 被引量：3
-
1王伟航,费锦锋,那万秋,许秋霞.抑郁症的增效治疗(二) 齐拉西酮对伴有精神病性症状抑郁症的治疗作用[J].临床精神医学杂志,2010,20(3):200-201. 被引量：2
-
2张奉玉,田博.度洛西汀联合拉莫三嗪治疗难治性抑郁症对照研究[J].精神医学杂志,2016,29(5):335-338. 被引量：11
-
3姜桂兰,曾波涛.小剂量奥氮平增效治疗难治性抑郁症的疗效观察[J].四川精神卫生,2010,23(3):168-169. 被引量：6
-
4常凤友.难治性抑郁症的增效治疗[J].中国煤炭工业医学杂志,2011,14(11):1730-1730. 被引量：5
-
5刘慧颖.齐拉西酮联合艾司西酞普兰增效治疗抑郁症的有效性和安全性探讨[J].中国初级卫生保健,2015,29(11):104-105.
-
6李祥.阿立哌唑增效治疗女性难治性精神分裂症的研究[J].中华全科医学,2013,11(10):1573-1573. 被引量：8
-
7卢葭,陈亮,谢鹏.阿立哌唑增效治疗难治性抑郁症的有效性和安全性的系统评价[J].中国医院药学杂志,2013,33(8):627-632. 被引量：7
-
8毛星.强迫症病因学研究的新进展[J].中国民康医学,2007,19(9):398-399.
-
9盛道启,杨艳军.万拉法新治疗强迫症对照研究[J].中国民康医学,2006,18(23):1008-1008.
-
10李海杰.齐拉西酮对强迫症增效治疗的临床研究[J].中国医药指南,2015,13(20):164-164. 被引量：3
